NCT04774887View on ClinicalTrials.gov

ERADICATING CERVICAL CANCER IN KENYA

NACompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

November 13, 2021

Primary Completion Date

October 18, 2023

Study Completion Date

October 18, 2023

Conditions
Human Papilloma VirusHIV Infections
Interventions
BIOLOGICAL

HPV vaccine, Merck

Vaccination against HPV will be offered to 900 children/grandchildren aged 9 through 18 of women attending the Community Meetings.

Trial Locations (1)

Unknown

Webuye Clinic, Webuye

All Listed Sponsors
collaborator

Moi University

OTHER

lead

Indiana University

OTHER

NCT04774887 - ERADICATING CERVICAL CANCER IN KENYA | Biotech Hunter | Biotech Hunter